Subtitle
Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma.
Subtitle
Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma.
Proto therapy Time
April 2020
Executive summary
Published by the NCC group in Korea, this study reported outcomes of 45 patients including 37 had recurrent and/or residual disease treated with PBT to a total dose of 70 Gy equivalent in 10 fractions. No grade ≥3 acute toxicity occurred. The median follow-up duration was 35.1 months, local progression occurred in two patients (8.7%).
The 3-year rates of LPFS and overall survival (OS) were 95.2% and 86.4%. The study concluded that hypofractionated PBT showed promising LPFS and OS.
Key content topics
Top cancer treatments
Related contents
Webinar
18 October 2024
Empowering Cancer Care with Proton Therapy
Rakesh
Jalali
Srinivas
Chilukuri
Daniela
Alterio
Proton Therapy Publication
July 2024
Quantifying dose uncertainties resulting from cardiorespiratory motion in intensity-modulated proton therapy for cardiac stereotactic body radiotherapy.
Proton Therapy Publication
July 2024
Initial experience and patient tolerance of proton stereotactic body radiotherapy.
Proton Therapy Publication
March 2024
A multicenter high-quality data registry for advanced proton therapy approaches: the POWER registry.
Webinar
March 29, 2023
Hypofractionation in Proton Therapy: radiobiological bases and clinical applications
Roberto
Orecchia
Barbara
Jereczek
Daniela
Alterio
Dante
Amelio
Jiri
Kubes
Proton Therapy Publication
March 2023
A retrospective study of adjuvant proton radiotherapy for breast cancer after lumpectomy: a comparison of conventional-dose and hypofractionated dose.
Proton Therapy Publication
November 2022
Hypofractionated proton therapy for non-small cell lung cancer: Ready for prime time? A systematic review and meta-analysis.
Proton Therapy Publication
May 2022
The Role of Hypofractionation in Proton Therapy.
Proton Therapy Publication
April 2022
Outcome after Radiotherapy for Vestibular Schwannomas – Differences in Tumor Control, Symptoms and Quality of Life after Radiotherapy with Photon versus Proton Therapy.